Cargando…

Cryptococcal pneumonia in a human immunodeficiency virus-negative patient: A case report

BACKGROUND: Cases of cryptococcal pneumonia are frequently observed in patients with various innate or acquired immunodeficiencies, including organ transplant patients, cancer patients undergoing chemotherapy, patients with acquired immune deficiency syndrome, or patients on dialysis. Fluconazole is...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xue-Qin, Zhang, Yan-Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262701/
https://www.ncbi.nlm.nih.gov/pubmed/32518798
http://dx.doi.org/10.12998/wjcc.v8.i10.2038
Descripción
Sumario:BACKGROUND: Cases of cryptococcal pneumonia are frequently observed in patients with various innate or acquired immunodeficiencies, including organ transplant patients, cancer patients undergoing chemotherapy, patients with acquired immune deficiency syndrome, or patients on dialysis. Fluconazole is most often used to treat this condition when it is detected. CASE SUMMARY: In the present report, we describe the case of a 42-year-old human immunodeficiency virus-negative man with normal immune function who had cryptococcal pneumonia that was diagnosed after undergoing computed tomography-guided percutaneous lung puncture. We successfully treated this patient via administration of 200 mg voriconazole twice per day for 9 mo. CONCLUSION: This report provides evidence of the successful treatment of pulmonary cryptococcosis using voriconazole.